Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6453]

Researchers identify how cancer cells adapt to survive harsh tumour microenvironments

Researchers identify how cancer cells adapt to survive harsh tumour microenvironments

FDA approves fam-trastuzumab deruxtecan-nxki for HER2-positive gastric adenocarcinomas

FDA approves fam-trastuzumab deruxtecan-nxki for HER2-positive gastric adenocarcinomas

New computational tool reliably differentiates between cancer and normal cells from single-cell RNA-sequencing data

New computational tool reliably differentiates between cancer and normal cells from single-cell RNA-sequencing data

New computational tool reliably differentiates between cancer and normal cells from single-cell RNA-sequencing data

New computational tool reliably differentiates between cancer and normal cells from single-cell RNA-sequencing data

CHOP researchers find NTRK fusions more common than expected in paediatric tumours

CHOP researchers find NTRK fusions more common than expected in paediatric tumours

New discovery in breast cancer treatment

New discovery in breast cancer treatment

Bladder cancer - When to use chemotherapy

Bladder cancer - When to use chemotherapy

$FDA approves crizotinib for children and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma$

FDA approves crizotinib for children and young adults with relapsed or refractory, systemic anaplastic large cell...

Oesophageal cancer patients show abundance of oral pathogens

Oesophageal cancer patients show abundance of oral pathogens

Triggering tumour antiviral immune response in triple negative breast cancer

Triggering tumour antiviral immune response in triple negative breast cancer

More from ecancer